Isoray, Inc. provided sales guidance for the first quarter ending September 30, 2022. In the short term, although the company don't have adequate supply now of Cesium-131, the company expects a decline in sales in the first fiscal quarter of 2023 ending September 30, 2022, versus the prior year. The company currently anticipates total revenue for this period to be between $1.6 million and $1.8 million.